Insurance coverage for GLP-1 medications can be revoked, plan structures change and patients who lose access to a drug can regain weight rapidly
Mechanistically it should, since it is a ghrelin-receptor agonist and ghrelin is the main circulating hunger signal
Para tratar de identificar si un fragmento especfico de GLP-q era una incretina, Mojsov cre un anticuerpo contra la incretina y desarroll formas de rastrear su presencia
Potential mechanisms include improvements in blood pressure, lipid profiles, body weight, inflammation, and endothelial function as well as direct cardioprotective effects on the cardiac muscle and vasculature [41]
Epic Research, which uses claims from the Epic electronic medical records data warehouse, which has over 200 million patient records, has published research demonstrating that the GLP-1 medications lead to sustained weight loss outside of clinical trials
Archived from the original on 20 November 2023